COMMUNIQUÉ DE PRESSE publié le 24/01/2024 à 14:00, il y a 7 mois 23 jours AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement AiCuris and the German Center for Infection Research (DZIF) have signed a collaboration and license option agreement to discover new active agents for the treatment and prophylaxis of infections of immunocompromised patients. The partnership aims to develop novel therapies for patients with high medical need. The financial details of the collaboration were not disclosed. For more information, visit www.dzif.de and www.aicuris.com. AiCuris German Center For Infection Research Collaboration License Option Agreement Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:00, il y a 11 mois 18 jours AiCuris´ AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 23/08/2023 à 14:00, il y a 1 année AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of PREVYMIS® (letermovir) in Second Indication
COMMUNIQUÉ DE PRESSE publié le 06/07/2023 à 14:00, il y a 1 année 2 mois AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
COMMUNIQUÉ DE PRESSE publié le 04/04/2023 à 14:00, il y a 1 année 5 mois AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary
Publié le 16/09/2024 à 18:00, il y a 3 heures 26 minutes Report on the Combined General Meeting of the 12th of September 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 26 minutes Compte-rendu d’Assemblée Générale Mixte du 12 septembre 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 26 minutes Programme de rachat d’actions propres : Déclaration des transactions sur actions propres réalisées du 9 septembre 2024 au 13 septembre 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 26 minutes Share buy-back program: Disclosure of trading in own shares from 9 September 2024 to 13 September 2024
Publié le 16/09/2024 à 18:00, il y a 3 heures 26 minutes imerys-16-09-2024-communique-capital-droits-de-vote-au-31-juillet-2024
Publié le 16/09/2024 à 21:05, il y a 21 minutes Actor Jeremy Renner Bringing an All-Star Charity Experience to Las Vegas
Publié le 16/09/2024 à 21:00, il y a 26 minutes SHPE, Nation’s Largest Organization of Top Hispanics in Stem, Celebrates 50 Years as It Hosts National Convention & Career Fair in Anaheim, Calif. October 30 - November 3
Publié le 16/09/2024 à 20:15, il y a 1 heure 11 minutes New to the Street's Episode 601 Will Air as Sponsored Programming on Fox Business at 10:30 PM PST, September 16, 2024. This Special Episode Will Feature In-Depth Interviews and Profiles of Industry-Leading Companies Driving Innovation in Their Respective
Publié le 16/09/2024 à 20:07, il y a 1 heure 19 minutes Nexera Provides Update#2 on Delayed Filing of Annual Financial Statements and MD&A and Management Cease Trade Order
Publié le 16/09/2024 à 20:00, il y a 1 heure 26 minutes Lender Market Unveils AI-Powered Financial Advisor Service for Business Owners
Publié le 16/09/2024 à 18:32, il y a 2 heures 53 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 16/09/2024 à 18:19, il y a 3 heures 7 minutes BILENDI: Bilendi dévoile 2 projets basés sur son intelligence artificielle générative BARI présentés au congrès mondial ESOMAR
Publié le 16/09/2024 à 17:59, il y a 3 heures 26 minutes EQS-Adhoc: Airbus reports share buyback transactions 9-13 September 2024
Publié le 16/09/2024 à 16:16, il y a 5 heures 10 minutes Original-Research: Netfonds AG (von Montega AG): Kaufen
Publié le 16/09/2024 à 15:28, il y a 5 heures 57 minutes Form 8.3 - The Vanguard Group, Inc.: International Paper Company